You have 9 free searches left this month | to do more

hdm201

Hdm201 is a drug used to treat AML, Adult, Acute Myeloid Leukemia (AML), Advanced Cancer, and other conditions. Hdm201 is being actively studied in 5 studies and prior, has been studied in 3.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative Site
Centre Leon BerardCentre Leon Berard
University Hospital Inselspital, BerneCentre Antoine LACASSAGNE
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • AML, Adult
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
2022-01-27
Jan 27, 2022
C
Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • (no location specified)
2021-12-20
Dec 20, 2021
N
Recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • HDM201
  • +2 more
  • Durham, North Carolina
  • +9 more
2022-03-23
Mar 23, 2022
N
Completed
  • Liposarcoma
  • Toronto, Ontario, Canada
  • +8 more
2020-12-06
Dec 6, 2020
N
Completed
  • Advanced Solid and Hematological TP53wt Tumors
  • HDM201
  • ancillary treatment
  • Boston, Massachusetts
  • +14 more
2021-05-20
May 20, 2021
N
Withdrawn
  • Leukemia, Myeloid, Acute
  • HDM201
  • +6 more
  • (no location specified)
2020-01-06
Jan 6, 2020
N
Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
2022-03-11
Mar 11, 2022